Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Egyptian study reveals why patients stop taking lifesaving meds

NCT ID NCT07375550

Knowledge-focused Sponsor: Egyptian Chinese University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at 261 adults with chronic diseases in Egypt to understand why they don't take their medications as prescribed. Researchers used a questionnaire to measure non-adherence and identify related factors like age, income, and side effects. The goal is to help pharmacists and doctors create better support strategies for patients.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could point toward better ways to help patients stick to their medications, improving disease control and reducing complications.
What could go wrong
This is an observational study, not a treatment trial. It identifies factors but does not test any intervention, so it cannot directly improve health.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

261 people

The number who actually took part.

Started

Jan 2026

Finished

Mar 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The study population consists of adult patients aged 18 to 80 years who have been diagnosed with at least one chronic disease and are receiving long-term pharmacological treatment. Participants will be recruited from community pharmacy settings across multiple Egyptian cities Eligible patients are those attending participating community pharmacies during the study period and who are capable of understanding the study procedures and providing written informed consent. The study population reflects a real-world sample of patients managing chronic conditions in community pharmacy practice in Egypt.

Ages

18 to 80 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 to 80 years. * Diagnosed with at least one chronic disease requiring long-term pharmacological treatment. * Currently receiving at least one prescribed medication for a chronic condition. * Attending a participating community pharmacy during the study period. * Able and willing to provide written informed consent. Exclusion Criteria: * Patients with cognitive impairment or mental conditions that limit their ability to understand the study procedures or complete the questionnaire. * Patients who refuse or are unable to provide written informed consent. * Patients who are acutely ill and unable to participate at the time of data collection.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chronic Disease Medication Adherence

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic disease

Contacts and locations

Locations

  • Community pharmacies

    Cairo, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.